Effect of Accelerated RTH in Squamous Cell Carcinoma in Head and Neck

NCT05291663 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-03-23

No results posted yet for this study

Summary

Evaluation of the efficacy of the accelerated radiotherapy in squamous cell carcinoma of head and neck

Conditions

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Mostafa El-sayed Abd Elwanis · Assiut University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-20
Primary Completion
2023-03-20
Completion
2023-12-20

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05291663 on ClinicalTrials.gov